본문 바로가기

Tableting process-induced solid-state polymorphic transition

문서 유형
연구출판물 · 리뷰논문
등재
KCISCIEScopus
저널 순위
Scopus Q1KCI Q1
저널
Journal of Pharmaceutical Investigation52(2) · pp.175 · 2022
피인용
Web of Science 30Scopus 33KCI 0
FWCI (Scopus)
0.9
ISSN
2093-5552

저자

  1. Park, Heejun제1저자Duksung Womens Univ, Coll Pharm, 33,Samyangro 144-Gil, Seoul 01369, South Korea
  2. Kim, Jeong-SooDong ST Co Ltd, Yongin 446905, Gyeonggi, South Korea
  3. Hong, SeongwooDuksung Womens Univ, Coll Pharm, 33,Samyangro 144-Gil, Seoul 01369, South Korea
  4. 하은솔Pusan Natl Univ, Coll Pharm, 2,Busandaehak Ro 63beon Gil, Busan 46241, South Korea
  5. Nie, HaichenMerck & Co Inc, Ctr Mat Sci & Engn, 770 Sumneytown Pike, West Point, PA 19486 USA
  6. Zhou, Qi Tony교신저자Purdue Univ, Dept Ind & Phys Pharm, Coll Pharm, 575 Stadium Mall Dr, W Lafayette, IN 47907 USA
  7. 김민수교신저자Pusan Natl Univ, Coll Pharm, 2,Busandaehak Ro 63beon Gil, Busan 46241, South Korea

초록

Background Polymorphism is that a substance exists into more than two crystalline forms with different molecular arrangements and/or conformations. It has been reported that the polymorphic transition significantly influences several important qualities of a solid drug product such as physical properties of dosage form, physicochemical stability, dissolution rate, permeability and absorption, bioavailability, manufacturability, and commercial scalability. Polymorphic transition can be altered by several pharmaceutical processes. Area covered This review paper discussed the tableting process-induced solid-state polymorphic transition in detail. In particular, the basic principles of solid-state polymorphic transition, theoretical hypotheses for their mechanism, solid-state characterization methods for the analysis of polymorphic transition, and research cases for various drugs in relation to polymorphic transition were reviewed. Expert opinion For the proper selection of the solid phase of raw materials, formulation design, and robust production process to assure the quality and performance of a final tablet product, the following are essential: (i) an in-depth knowledge based on fundamental understanding of the polymorphic transition mechanisms, (ii) development of a promising analytical technology as a process analytical technology (PAT) available for in situ and in-die real-time measurement of a very small quantity of polymorphic transformation with high sensitivity, and iii) development of a complete technology in the formulation and process that can finely control the undesired polymorphic transition.

키워드

Polymorphic transitionStabilitySolid-stateTabletingCompactionProcess analytical technology (PAT)ACTIVE PHARMACEUTICAL INGREDIENTSINDUCED-TRANSFORMATIONS PITSDIRECT COMPRESSION IMPACTAMORPHOUS INDOMETHACINPHASE-TRANSFORMATIONSPHYSICAL STABILITYENVIRONMENTAL-TEMPERATURESURFACE CRYSTALLIZATIONQUANTITATIVE-ANALYSISMETASTABLE POLYMORPH

식별자

Scopus EID
2-s2.0-85122307853
WoS UID
000738489100001
KCI
ART002821433